NIHR biomarker pipleline programme is a collaboration between various academic research groups spread around the country and NHS Leeds Teaching Hospital and NHS Lothian. This unique collaboration capitalises on the existing expertise and long-standing links between the two organisations and provides the best environment for collaborative research, promoting unparalleled interaction between clinicians and researchers.
The £2 million programme grant is funded by National Institute of Health Research (NIHR).
The research programme will benefit patients and the NHS by ensuring that biomarkers in the future can be evaluated and introduced more rapidly, improving clinical management for each individual patient and leading to better use of NHS resources. While our research proposal focuses on diseases of the liver and kidney, in the future it can also serve as the "blueprint" for similar work in other diseases.
The Programme is being coordinated in Leeds, jointly between the Leeds Institute of Cancer and Pathology (LICAP) and Health Sciences (LIHS) within the Faculty of Medicine and Health at the University but involves collaborations at the national level. This integrated research programme involves a multi-disciplinary team of health economists, statisticians, scientists and clinicians, as well as collaboration with colleagues from the diagnostic industry, click here to see a diagramatic representation of our collaborative structure.
The NIHR biomarker pipeline is a collaboration of some of the finest scientists in the field of liver/renal/kidney cancers in the world. We are proud to have the following individuals collaborating on the project.